Similar to previous studies, SPP1 [27,28], MTHFD2 [29,30], TRIP13 [31,32], MKI67 [33,34], MMP9 [35,36], and KLF4 [37,38] were some of the most clinically valuable tumor markers, especially in CC and EC. This evidence concerns the gene MTHFD2 and neoplasm.